News Weakened May to cling on after shock UK election result, Bre... British politics have once again been rocked by a massive shock result.
Views & Analysis New UK law to control generic drug prices - implications for... The aims and implications of the Health Service Medical Supplies (Costs) Act 2017.
News Bad Brexit deal threatens plan to hire NHS staff Jeremy Hunt admits a bad Brexit deal could threaten plans to hire more NHS staff.
Debates & Insight Sponsored Disruption and maturity: the future directions for biologics Is the UK’s NHS saving enough from the new wave of biosimilars?
Views & Analysis The UK general election: what pharma wants As the UK election approaches how do the main parties measure up regarding health funding?
Events Partner Content FT Digital Health Summit Europe - London, 27 June 2017 Converting ambition into reality, outcomes and value
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
